{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:13:52Z","timestamp":1791994432261,"version":"4.4.0"},"reference-count":293,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prevention of epilepsy is a great unmet need. Acute central nervous system (CNS) insults such as traumatic brain injury (TBI), cerebrovascular accidents (CVA), and CNS infections account for 15%\u201020% of all epilepsy. Following TBI and CVA, there is a latency of days to years before epilepsy develops. This allows treatment to prevent or modify postinjury epilepsy. No such treatment exists. In animal models of acquired epilepsy, a number of medications in clinical use for diverse indications have been shown to have antiepileptogenic or disease\u2010modifying effects, including medications with excellent side effect profiles. These include atorvastatin, ceftriaxone, losartan, isoflurane, N\u2010acetylcysteine, and the antiseizure medications levetiracetam, brivaracetam, topiramate, gabapentin, pregabalin, vigabatrin, and eslicarbazepine acetate. In addition, there are preclinical antiepileptogenic data for anakinra, rapamycin, fingolimod, and erythropoietin, although these medications have potential for more serious side effects. However, except for vigabatrin, there have been almost no translation studies to prevent or modify epilepsy using these potentially \u201crepurposable\u201d medications. We may be missing an opportunity to develop preventive treatment for epilepsy by not evaluating these medications clinically. One reason for the lack of translation studies is that the preclinical data for most of these medications are disparate in terms of types of injury, models within different injury type, dosing, injury\u2013treatment initiation latencies, treatment duration, and epilepsy outcome evaluation mode and duration. This makes it difficult to compare the relative strength of antiepileptogenic evidence across the molecules, and difficult to determine which drug(s) would be the best to evaluate clinically. Furthermore, most preclinical antiepileptogenic studies lack information needed for translation, such as dose\u2013blood level relationship, brain target engagement, and dose\u2010response, and many use treatment parameters that cannot be applied clinically, for example, treatment initiation before or at the time of injury and dosing higher than tolerated human equivalent dosing. Here, we review animal and human antiepileptogenic evidence for these medications. We highlight the gaps in our knowledge for each molecule that need to be filled\u00a0in order to consider clinical translation, and we suggest a platform of preclinical antiepileptogenesis evaluation of potentially repurposable molecules or their combinations going forward.<\/jats:p>","DOI":"10.1111\/epi.16450","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T14:30:37Z","timestamp":1584714637000},"page":"359-386","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?"],"prefix":"10.1111","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7244-3722","authenticated-orcid":false,"given":"Pavel","family":"Klein","sequence":"first","affiliation":[{"name":"Mid\u2010Atlantic Epilepsy and Sleep Center Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Friedman","sequence":"additional","affiliation":[{"name":"Departments of Physiology and Cell Biology, and Brain and Cognitive Science Zlotowski Center for Neuroscience Ben\u2010Gurion University of the Negev Beer\u2010Sheva Israel"},{"name":"Departments of Medical Neuroscience and Brain Repair Center Dalhousie University Halifax Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Q.","family":"Hameed","sequence":"additional","affiliation":[{"name":"Neuromodulation Program Division of Epilepsy and Clinical Neurophysiology Department of Neurology Boston Children\u2019s Hospital Harvard Medical School Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal M.","family":"Kaminski","sequence":"additional","affiliation":[{"name":"Neurosymptomatic Domains Section Roche Pharma Research &amp; Early Development Roche Innovation Center Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Bar\u2010Klein","sequence":"additional","affiliation":[{"name":"McKusick\u2010Nathans Institute of Genetic Medicine Howard Hughes Medical Institute Johns Hopkins University School of Medicine Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Klitgaard","sequence":"additional","affiliation":[{"name":"Neurosciences Therapeutic Area UCB Pharma Braine\u2010l\u2019Alleud Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Koepp","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy University College London Institute of Neurology London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiusz","family":"Jozwiak","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology Warsaw Medical University Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Prince","sequence":"additional","affiliation":[{"name":"Neurology and the Neurological Sciences Stanford University School of Medicine Stanford California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rotenberg","sequence":"additional","affiliation":[{"name":"Neuromodulation Program Division of Epilepsy and Clinical Neurophysiology Department of Neurology Boston Children\u2019s Hospital Harvard Medical School Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Twyman","sequence":"additional","affiliation":[{"name":"Amron Neuroscience Darby, Montana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Vezzani","sequence":"additional","affiliation":[{"name":"Department of Neuroscience Mario Negri Institute for Pharmacological Research, Scientific Institute for Research and Health Care Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3796-743X","authenticated-orcid":false,"given":"Michael","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Neurology Washington University School of Medicine St Louis Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9648-8973","authenticated-orcid":false,"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology, and Pharmacy University of Veterinary Medicine Hannover Germany"},{"name":"Center for Systems Neuroscience Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"e_1_2_22_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13965"},{"key":"e_1_2_22_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2009.03.003"},{"key":"e_1_2_22_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1993.tb02586.x"},{"key":"e_1_2_22_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2017.05.024"},{"key":"e_1_2_22_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-014-0266-1"},{"key":"e_1_2_22_7_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.003046"},{"key":"e_1_2_22_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.445"},{"issue":"2","key":"e_1_2_22_9_1","first-page":"474","article-title":"Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy","volume":"284","author":"L\u00f6scher W","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_22_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(02)00254-1"},{"key":"e_1_2_22_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90855-X"},{"key":"e_1_2_22_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(98)00016-3"},{"key":"e_1_2_22_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01594.x"},{"key":"e_1_2_22_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.35204.x"},{"key":"e_1_2_22_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03112.x"},{"key":"e_1_2_22_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.05.001"},{"key":"e_1_2_22_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1059131102001930"},{"key":"e_1_2_22_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2012.05.011"},{"key":"e_1_2_22_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2015.03.005"},{"key":"e_1_2_22_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2016.09.038"},{"key":"e_1_2_22_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2008.07.006"},{"key":"e_1_2_22_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2016.04.013"},{"key":"e_1_2_22_23_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23923"},{"key":"e_1_2_22_24_1","unstructured":"LingD YangL AfrozS et al.Levetiracetam prevents posttraumatic epileptogenesis in rat neocortex following controlled cortical impact injury. Paper presented at: American Epilepsy Society 2011 Annual Meeting; December 1\u20105 2011; Baltimore MD; Abstract 1.284."},{"issue":"11","key":"e_1_2_22_25_1","first-page":"265","article-title":"Levetiracetam and leupeptin prevent post\u2010traumatic epileptogenesis in an in vitro model of neocortical injury","volume":"50","author":"Ling D","year":"2009","journal-title":"Epilepsia"},{"key":"e_1_2_22_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2007.03.021"},{"key":"e_1_2_22_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2015.4131"},{"key":"e_1_2_22_28_1","doi-asserted-by":"publisher","DOI":"10.3233\/RNN-150580"},{"key":"e_1_2_22_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03453.x"},{"key":"e_1_2_22_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0384-x"},{"key":"e_1_2_22_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02089.x"},{"key":"e_1_2_22_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep27420"},{"key":"e_1_2_22_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00210"},{"key":"e_1_2_22_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01727.x"},{"key":"e_1_2_22_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2012.06.058"},{"key":"e_1_2_22_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00148"},{"key":"e_1_2_22_37_1","first-page":"463","article-title":"Therapeutic role of synaptic vesicle glycoprotein 2A (SV2A) in modulating epileptogenesis","volume":"16","author":"Ohno Y","year":"2017","journal-title":"Neurol Disord Drug Targets"},{"key":"e_1_2_22_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2018.01.004"},{"key":"e_1_2_22_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-006-9132-y"},{"key":"e_1_2_22_40_1","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2016-0034"},{"key":"e_1_2_22_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2008.02.076"},{"key":"e_1_2_22_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13340"},{"key":"e_1_2_22_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00436-O"},{"key":"e_1_2_22_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.198"},{"key":"e_1_2_22_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13638"},{"key":"e_1_2_22_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12973"},{"key":"e_1_2_22_47_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1751-04.2004"},{"key":"e_1_2_22_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2006.10.006"},{"key":"e_1_2_22_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl317"},{"key":"e_1_2_22_50_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0430-09.2009"},{"key":"e_1_2_22_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00432-X"},{"key":"e_1_2_22_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/35043051"},{"key":"e_1_2_22_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3434"},{"key":"e_1_2_22_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2011.12.013"},{"key":"e_1_2_22_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03666.x"},{"key":"e_1_2_22_56_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2323-09.2009"},{"key":"e_1_2_22_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07394-3"},{"key":"e_1_2_22_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.02.029"},{"key":"e_1_2_22_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2016.03.008"},{"key":"e_1_2_22_60_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.6.789"},{"key":"e_1_2_22_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000182521.44440.c5"},{"key":"e_1_2_22_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1536"},{"key":"e_1_2_22_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24147"},{"key":"e_1_2_22_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2018.05.027"},{"key":"e_1_2_22_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2014.10.005"},{"key":"e_1_2_22_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx073"},{"issue":"2","key":"e_1_2_22_67_1","first-page":"69","article-title":"The effects of chronic losartan pretreatment on restraint stress\u2010induced changes in motor activity, nociception and pentylenetetrazol generalized seizures in rats","volume":"53","author":"Pechlivanova DM","year":"2011","journal-title":"Folia Med"},{"key":"e_1_2_22_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2015.02.014"},{"key":"e_1_2_22_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2005.11.005"},{"key":"e_1_2_22_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.225"},{"key":"e_1_2_22_71_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.192401"},{"key":"e_1_2_22_72_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6873"},{"key":"e_1_2_22_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.11.022"},{"key":"e_1_2_22_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2012.06.010"},{"key":"e_1_2_22_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2010.110"},{"key":"e_1_2_22_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.152"},{"key":"e_1_2_22_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu197"},{"key":"e_1_2_22_78_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31822f08b9"},{"key":"e_1_2_22_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.04.018"},{"key":"e_1_2_22_80_1","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2013.074336"},{"key":"e_1_2_22_81_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016037"},{"key":"e_1_2_22_82_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.121771"},{"key":"e_1_2_22_83_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000141573.44737.5A"},{"key":"e_1_2_22_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.10.068"},{"key":"e_1_2_22_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.12.025"},{"issue":"6","key":"e_1_2_22_86_1","first-page":"1175","article-title":"Stroke prevention with the angiotensin II type 1\u2010receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE)","volume":"44","author":"Papademetriou V","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_22_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200305000-00011"},{"key":"e_1_2_22_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8659-z"},{"key":"e_1_2_22_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.04.027"},{"key":"e_1_2_22_90_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1992.sp019086"},{"key":"e_1_2_22_91_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0463-7"},{"key":"e_1_2_22_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(01)03044-X"},{"key":"e_1_2_22_93_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199206000-00020"},{"key":"e_1_2_22_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0265-0215.1998.00275.x"},{"key":"e_1_2_22_95_1","doi-asserted-by":"publisher","DOI":"10.1179\/174313209X393546"},{"key":"e_1_2_22_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2013.09.016"},{"key":"e_1_2_22_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24804"},{"key":"e_1_2_22_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2017.02.007"},{"key":"e_1_2_22_99_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170682"},{"key":"e_1_2_22_100_1","doi-asserted-by":"publisher","DOI":"10.1179\/1743132814Y.0000000341"},{"key":"e_1_2_22_101_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.661728"},{"key":"e_1_2_22_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3800"},{"key":"e_1_2_22_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.054882"},{"key":"e_1_2_22_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2014.23"},{"key":"e_1_2_22_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0217-x"},{"key":"e_1_2_22_106_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1192-7"},{"key":"e_1_2_22_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.08.020"},{"key":"e_1_2_22_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12444"},{"key":"e_1_2_22_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1481-5"},{"key":"e_1_2_22_110_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24806"},{"key":"e_1_2_22_111_1","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9899.1000456"},{"key":"e_1_2_22_112_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1063-2"},{"key":"e_1_2_22_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12317"},{"key":"e_1_2_22_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03033.x"},{"key":"e_1_2_22_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2011.09.033"},{"key":"e_1_2_22_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2011.02.040"},{"key":"e_1_2_22_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.05.015"},{"key":"e_1_2_22_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2011.05.003"},{"key":"e_1_2_22_119_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0764-7"},{"key":"e_1_2_22_120_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0551-10.2010"},{"key":"e_1_2_22_121_1","article-title":"Inflammation and reactive oxygen species as disease modifiers in epilepsy","author":"Terrone G","year":"2019","journal-title":"Neuropharmacology"},{"key":"e_1_2_22_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2016.12.007"},{"key":"e_1_2_22_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2011.03.018"},{"key":"e_1_2_22_124_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13786"},{"key":"e_1_2_22_125_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-9574LSF"},{"key":"e_1_2_22_126_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-30"},{"key":"e_1_2_22_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2013.07.015"},{"key":"e_1_2_22_128_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz130"},{"key":"e_1_2_22_129_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02606.x"},{"key":"e_1_2_22_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2019.08.001"},{"key":"e_1_2_22_131_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1831"},{"key":"e_1_2_22_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2011.08.005"},{"key":"e_1_2_22_133_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-012-2118-2"},{"key":"e_1_2_22_134_1","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2013-0241"},{"key":"e_1_2_22_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.02.002"},{"key":"e_1_2_22_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.07.005"},{"key":"e_1_2_22_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2016.05.013"},{"key":"e_1_2_22_138_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy071"},{"key":"e_1_2_22_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101278"},{"key":"e_1_2_22_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.06.030"},{"key":"e_1_2_22_141_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0682-09.2009"},{"key":"e_1_2_22_142_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001814"},{"key":"e_1_2_22_143_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f96253"},{"key":"e_1_2_22_144_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.02124.x"},{"key":"e_1_2_22_145_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03261.x"},{"key":"e_1_2_22_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.01.034"},{"key":"e_1_2_22_147_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450116666150330114850"},{"key":"e_1_2_22_148_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M707442200"},{"key":"e_1_2_22_149_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20875"},{"key":"e_1_2_22_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2017.08.016"},{"key":"e_1_2_22_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2017.10.021"},{"key":"e_1_2_22_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2014.11.011"},{"key":"e_1_2_22_153_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12686"},{"key":"e_1_2_22_154_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03073.x"},{"key":"e_1_2_22_155_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024966"},{"key":"e_1_2_22_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2014.04.009"},{"key":"e_1_2_22_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.08.043"},{"key":"e_1_2_22_158_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20744"},{"key":"e_1_2_22_159_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-014-1473-1"},{"key":"e_1_2_22_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(00)00067-8"},{"key":"e_1_2_22_161_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-21-08751.1998"},{"key":"e_1_2_22_162_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5319.1699"},{"key":"e_1_2_22_163_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2018.5632"},{"key":"e_1_2_22_164_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.70052020.x"},{"key":"e_1_2_22_165_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2012.2712"},{"key":"e_1_2_22_166_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2015.4372"},{"key":"e_1_2_22_167_1","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhy328"},{"key":"e_1_2_22_168_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2008.06494.x"},{"key":"e_1_2_22_169_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M600653200"},{"key":"e_1_2_22_170_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-06-01876.2001"},{"key":"e_1_2_22_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2003.12.007"},{"key":"e_1_2_22_172_1","first-page":"17","article-title":"CSF and ECF glutamate concentrations in head injured patients","volume":"75","author":"Yamamoto T","year":"1999","journal-title":"Acta Neurochir Suppl"},{"key":"e_1_2_22_173_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00482"},{"key":"e_1_2_22_174_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.4.6.2180770"},{"key":"e_1_2_22_175_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01480.x"},{"key":"e_1_2_22_176_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.03921.x"},{"key":"e_1_2_22_177_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026013394741"},{"key":"e_1_2_22_178_1","doi-asserted-by":"publisher","DOI":"10.1002\/dneu.20853"},{"key":"e_1_2_22_179_1","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3701-3-19"},{"key":"e_1_2_22_180_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature07991"},{"key":"e_1_2_22_181_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2012.238154"},{"key":"e_1_2_22_182_1","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhw318"},{"key":"e_1_2_22_183_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-013-1585-4"},{"key":"e_1_2_22_184_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100230"},{"key":"e_1_2_22_185_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2015.04.005"},{"key":"e_1_2_22_186_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186243"},{"key":"e_1_2_22_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2017.05.002"},{"key":"e_1_2_22_188_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03180"},{"key":"e_1_2_22_189_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M707697200"},{"key":"e_1_2_22_190_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2009.06347.x"},{"key":"e_1_2_22_191_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8809-3"},{"key":"e_1_2_22_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2015.07.008"},{"key":"e_1_2_22_193_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.22671"},{"key":"e_1_2_22_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.10.095"},{"key":"e_1_2_22_195_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.09.025"},{"key":"e_1_2_22_196_1","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199746545.003.0075"},{"key":"e_1_2_22_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2006.09.008"},{"key":"e_1_2_22_198_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2013.04.001"},{"key":"e_1_2_22_199_1","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.2000.0407"},{"key":"e_1_2_22_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2012.06.019"},{"key":"e_1_2_22_201_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2017.01.009"},{"key":"e_1_2_22_202_1","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0316-17.2017"},{"key":"e_1_2_22_203_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.08.022"},{"key":"e_1_2_22_204_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.02.021"},{"key":"e_1_2_22_205_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(00)00103-9"},{"key":"e_1_2_22_206_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2003.61802.x"},{"key":"e_1_2_22_207_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078516"},{"key":"e_1_2_22_208_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph10040093"},{"key":"e_1_2_22_209_1","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e318174e70e"},{"key":"e_1_2_22_210_1","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhx152"},{"key":"e_1_2_22_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2016.11.009"},{"key":"e_1_2_22_212_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S512"},{"key":"e_1_2_22_213_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1430"},{"issue":"7","key":"e_1_2_22_214_1","first-page":"15","article-title":"Topiramate is both neuroprotective and antiepileptogenic in the pilocarpine model of status epilepticus","volume":"43","author":"DeLorenzo RJ","year":"2002","journal-title":"Epilepsia"},{"key":"e_1_2_22_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104664"},{"key":"e_1_2_22_216_1","doi-asserted-by":"publisher","DOI":"10.1203\/01.pdr.0000196333.16608.30"},{"key":"e_1_2_22_217_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(02)00157-2"},{"key":"e_1_2_22_218_1","first-page":"73:173\u201380","article-title":"Amelioration of water maze performance deficits by topiramate applied during pilocarpine\u2010induced status epilepticus is negatively dose\u2010dependent","author":"Frisch C","year":"2007","journal-title":"Epilepsy Res"},{"key":"e_1_2_22_219_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(98)00021-7"},{"key":"e_1_2_22_220_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.00987.x"},{"key":"e_1_2_22_221_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02607.x"},{"key":"e_1_2_22_222_1","doi-asserted-by":"publisher","DOI":"10.1089\/089771504774129847"},{"key":"e_1_2_22_223_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.017"},{"key":"e_1_2_22_224_1","doi-asserted-by":"publisher","DOI":"10.4103\/2319-4170.110365"},{"key":"e_1_2_22_225_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.81"},{"key":"e_1_2_22_226_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2016.11.017"},{"key":"e_1_2_22_227_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02341.x"},{"key":"e_1_2_22_228_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21331"},{"key":"e_1_2_22_229_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13031"},{"key":"e_1_2_22_230_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2982"},{"key":"e_1_2_22_231_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03506.x"},{"key":"e_1_2_22_232_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2010.05.024"},{"key":"e_1_2_22_233_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23943"},{"key":"e_1_2_22_234_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.08.002"},{"key":"e_1_2_22_235_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.12835"},{"key":"e_1_2_22_236_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13345"},{"key":"e_1_2_22_237_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064078"},{"key":"e_1_2_22_238_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.11.020"},{"issue":"4","key":"e_1_2_22_239_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.33549\/physiolres.930209","article-title":"Does vigabatrin possess an anticonvulsant action against pentylenetetrazol\u2010induced seizures in developing rats?","volume":"51","author":"Haugvicov\u00e1 R","year":"2002","journal-title":"Physiol Res"},{"key":"e_1_2_22_240_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)91498-8"},{"key":"e_1_2_22_241_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2004.08.013"},{"key":"e_1_2_22_242_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(00)00183-0"},{"key":"e_1_2_22_243_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)11766-P"},{"key":"e_1_2_22_244_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(98)00074-6"},{"key":"e_1_2_22_245_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(01)00299-6"},{"key":"e_1_2_22_246_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2011.07.030"},{"key":"e_1_2_22_247_1","doi-asserted-by":"publisher","DOI":"10.1177\/088307389901400201"},{"key":"e_1_2_22_248_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057445"},{"key":"e_1_2_22_249_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0764-z"},{"key":"e_1_2_22_250_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2011.03.010"},{"key":"e_1_2_22_251_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2019.07.008"},{"key":"e_1_2_22_252_1","unstructured":"JozwiakS.Long\u2010term prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy\u2014tuberous sclerosis complex (EPISTOP).2014[cited 2020 Feb 18]. Available at:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02098759?term=NCT02098759%26rank=1."},{"key":"e_1_2_22_253_1","unstructured":"BebinM.Preventing epilepsy using vigabatrin in infants with tuberous sclerosis complex.2016[cited 2020 Feb 18]. Available at:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02849457?term=NCT02849457%26rank=1."},{"key":"e_1_2_22_254_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm980627g"},{"key":"e_1_2_22_255_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu339"},{"key":"e_1_2_22_256_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1421-08.2008"},{"key":"e_1_2_22_257_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-09-03645.2002"},{"key":"e_1_2_22_258_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2011.04.002"},{"key":"e_1_2_22_259_1","first-page":"CD005398","article-title":"Antiepileptic drugs for the primary and secondary prevention of seizures after stroke","volume":"1","author":"Sykes L","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_22_260_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181cbf825"},{"key":"e_1_2_22_261_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00283"},{"key":"e_1_2_22_262_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2012.08.025"},{"key":"e_1_2_22_263_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1181-y"},{"key":"e_1_2_22_264_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0550-y"},{"key":"e_1_2_22_265_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12973"},{"key":"e_1_2_22_266_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.01.012"},{"key":"e_1_2_22_267_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0318-0"},{"key":"e_1_2_22_268_1","doi-asserted-by":"publisher","DOI":"10.1177\/1073858411422754"},{"key":"e_1_2_22_269_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00084"},{"key":"e_1_2_22_270_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004608"},{"key":"e_1_2_22_271_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-016-0701-2"},{"key":"e_1_2_22_272_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.118"},{"key":"e_1_2_22_273_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1011-1166"},{"key":"e_1_2_22_274_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4126"},{"key":"e_1_2_22_275_1","doi-asserted-by":"publisher","DOI":"10.1002\/minf.201700048"},{"key":"e_1_2_22_276_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-013-0250-1"},{"key":"e_1_2_22_277_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1993.tb00224.x"},{"key":"e_1_2_22_278_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90514-2"},{"key":"e_1_2_22_279_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12368-6"},{"key":"e_1_2_22_280_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.222"},{"key":"e_1_2_22_281_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1230-6"},{"key":"e_1_2_22_282_1","first-page":"947","article-title":"AMPA receptors in epilepsy and as targets for antiepileptic drugs","volume":"79","author":"Rogawski MA","year":"1999","journal-title":"Adv Neurol"},{"key":"e_1_2_22_283_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0633-10.2010"},{"key":"e_1_2_22_284_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3819"},{"key":"e_1_2_22_285_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2006.07.014"},{"key":"e_1_2_22_286_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.057091"},{"key":"e_1_2_22_287_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3078"},{"key":"e_1_2_22_288_1","unstructured":"United States Patent and Trademark Office. General information concerning patents. October 2015.[cited 2020 Feb 18]. Available at:https:\/\/www.uspto.gov\/patents-getting-started\/general-information-concerning-patents."},{"key":"e_1_2_22_289_1","doi-asserted-by":"publisher","DOI":"10.4103\/0975-7406.62694"},{"key":"e_1_2_22_290_1","unstructured":"US Food and Drug Administration. Development & approval process | drugs.[cited 2020 Feb 18]. Available at:https:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/default.htm."},{"key":"e_1_2_22_291_1","unstructured":"European Commission Enterprise and Industry Directorate\u2010General. Guidance on elements required to support the significant clinical benefit in comparison with existing therapies of a new therapeutic indication in order to benefit from an extended (11\u2010year) marketing protection period. November 2007. [cited 2020 Feb 18]. Available at:https:\/\/ec.europa.eu\/health\/\/sites\/health\/files\/files\/eudralex\/vol-2\/c\/guideline_14-11-2007_en.pdf."},{"key":"e_1_2_22_292_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.04.011"},{"key":"e_1_2_22_293_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.07.025"},{"key":"e_1_2_22_294_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976-0105.177703"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fepi.16450","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/epi.16450","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/epi.16450","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/epi.16450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T13:09:56Z","timestamp":1722604196000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/epi.16450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":293,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1111\/epi.16450"],"URL":"https:\/\/doi.org\/10.1111\/epi.16450","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"2019-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}